Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Aug 13, 2021

SELL
$25.45 - $37.64 $1.42 Million - $2.1 Million
-55,666 Closed
0 $0
Q1 2021

May 14, 2021

SELL
$29.16 - $51.96 $351,611 - $626,533
-12,058 Reduced 17.8%
55,666 $1.68 Million
Q4 2020

Feb 02, 2021

SELL
$37.86 - $54.26 $49,218 - $70,538
-1,300 Reduced 1.88%
67,724 $3.35 Million
Q3 2020

Nov 05, 2020

BUY
$35.13 - $43.62 $66,747 - $82,878
1,900 Added 2.83%
69,024 $2.65 Million
Q2 2020

Aug 12, 2020

BUY
$23.66 - $49.53 $388,757 - $813,827
16,431 Added 32.41%
67,124 $2.9 Million
Q1 2020

May 12, 2020

BUY
$14.39 - $35.8 $162,031 - $403,107
11,260 Added 28.55%
50,693 $1.32 Million
Q4 2019

Jan 27, 2020

BUY
$23.81 - $33.78 $706,442 - $1 Million
29,670 Added 303.9%
39,433 $1.23 Million
Q3 2019

Oct 31, 2019

BUY
$21.57 - $31.37 $210,587 - $306,265
9,763 New
9,763 $254,000

Others Institutions Holding YMAB

About Y-mAbs Therapeutics, Inc.


  • Ticker YMAB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 43,719,500
  • Market Cap $487M
  • Description
  • Y-mAbs Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the development and commercialization of novel antibody based therapeutic products for the treatment of cancer in the United States. It offers DANYELZA, a monoclonal antibody in combination with granulocyte-macrophage colony-stimulating factor for the treatment o...
More about YMAB
Track This Portfolio

Track California Public Employees Retirement System Portfolio

Follow California Public Employees Retirement System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of California Public Employees Retirement System, based on Form 13F filings with the SEC.

News

Stay updated on California Public Employees Retirement System with notifications on news.